本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bone Biologics Corp

0.5400
-0.0001-0.02%
盤後0.54000.00000.00%16:10 EDT
成交量:10.38萬
成交額:5.57萬
市值:148.83萬
市盈率:-0.34
高:0.5798
開:0.5320
低:0.5101
收:0.5401
52周最高:2.89
52周最低:0.5101
股本:275.61萬
流通股本:275.54萬
量比:3.99
換手率:3.77%
股息:- -
股息率:- -
每股收益(TTM):-1.6080
每股收益(LYR):-2.6500
淨資產收益率:-54.96%
總資產收益率:-33.46%
市淨率:0.38
市盈率(LYR):-0.20

資料載入中...

2023/11/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/20

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

重要事件披露

Form 8-K - Current report
2023/09/30

重要事件披露

Form 8-K - Current report
2023/09/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/09/13

重要事件披露

Form 8-K - Current report
2023/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/06

重要事件披露

Form 8-K - Current report
2023/06/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/17

重要事件披露

Form 8-K - Current report
2023/06/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/06/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/13

SEC問詢函

Form CORRESP - Correspondence
2023/06/07

重要事件披露

Form 8-K - Current report
2023/06/06

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/19

重要事件披露

Form 8-K - Current report
2023/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/01

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933